News

Biotech's Boom Suffers a Setback in March April 01, 2014 | Press Release

Investors Flock to Biotech March 03, 2014 | Press Release

Biotech IPOs Off to a Strong Start in 2014 February 03, 2014 | Press Release

  See all News
 
Sign up for a free subscription to The Burrill Weekly Brief 
Sign up to receive email notifications about our upcoming events and news.


Victor A. Hebert joins Burrill & Company

October 10, 2008

Burrill & Company, a San Francisco based global leader in the life sciences with principal activities in Venture Capital, Private Equity, Merchant Banking and Media, announced that Victor A. Hebert has joined the firm as Managing Director and Chief Legal Officer.

Before joining Burrill & Company, Vic spent his entire legal career at Heller Ehrman LLP.  He is a business lawyer with extensive experience in mergers and acquisitions, corporate finance and corporate governance.  In the area of venture capital, Vic has assisted in fund formation, financing transactions for purchasers and issuers, and the representation of many emerging growth companies.  Vic has handled numerous mergers and acquisitions for public and private clients, including leverage buyout transactions.  Vic has been involved in many public and private offerings of debt and equity securities for issuers and underwriters.  Vic has also been involved in a variety of domestic and international joint ventures.

Vic holds bachelor and law degrees from the University California. 

G. Steven Burrill, CEO of Burrill & Company said: “I have known and worked with Vic for many years.  We are very pleased that Vic has joined Burrill & Company following his distinguished legal career in private practice.  We are confident that Vic’s broad experience will help Burrill & Company and its clients and portfolio companies to achieve their objectives.”

About Burrill & Company
Founded in 1994, Burrill & Company is a San Francisco-based global leader in life sciences with activities in Venture Capital, Private Equity, Merchant Banking and Media. The Burrill family of venture capital funds has over $950 million under management and its merchant banking business is one of the industry leaders in life sciences transactions.
 
Burrill is also the creator, sponsor and facilitator of over a dozen leading industry conferences worldwide and publishes a range of bio-intelligence reports including the monthly Burrill Biotechnology Report and annual “State of the Industry” report, the 22nd Edition is entitled Biotech 2008: Life Sciences – A 20/20 Vision to 2020.

Back to News list  
News Archive: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | View All